The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 59,000% year to date.
Category: Finance News
Nasdaq-traded Chinese herb stock with no revenues rallies 59,000% to top Lululemon in market value
The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 59,000% year to date.
The Fed is likely to keep rates the same but give a forecast that moves markets. What to expect
While any movement on interest rates seems improbable, the meeting will feature important signals that still could move markets.
The Fed is likely to keep rates the same but give a forecast that moves markets. What to expect
While any movement on interest rates seems improbable, the meeting will feature important signals that still could move markets.
Stocks making the biggest moves midday: Jabil, JetBlue, Sunrun, Valero, Verve Therapeutics and more
These are some of the stocks posting the largest moves in midday trading.
Nasdaq-traded Chinese herb stock with no revenues rallies 58,000% to top Lululemon in market value
The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 58,000% year to date.
Nasdaq-traded Chinese herb stock with no revenues rallies 58,000% to top Lululemon in market value
The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 58,000% year to date.
Nasdaq-traded Chinese herb stock with no revenues rallies 58,000% to top Lululemon in market value
The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 40,000% year to date.
Nasdaq-traded Chinese herb stock with no revenues rallies 58,000% to top Lululemon in market value
The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 40,000% year to date.
Stocks making the biggest moves midday: Jabil, JetBlue, Sunrun, Valero, Verve Therapeutics and more
These are some of the stocks posting the largest moves in midday trading.